{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:34:46Z","timestamp":1793756086666,"version":"4.6.1"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/2\/2018-Hum\/BMS"],"award-info":[{"award-number":["45\/2\/2018-Hum\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["31.05.2018"],"award-info":[{"award-number":["31.05.2018"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ensci.2020.100270","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:38:03Z","timestamp":1599687483000},"page":"100270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"special_numbering":"C","title":["Kynurenine pathway in Parkinson's disease\u2014An update"],"prefix":"10.1016","volume":"21","author":[{"given":"Dhivya","family":"Venkatesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahalaxmi","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Narayanasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalakannan","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ensci.2020.100270_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainresbull.2020.02.001","article-title":"Unraveling correlative roles of dopamine transporter (DAT) and parkin in Parkinson\u2019s disease (PD)-a road to discovery?","volume":"157","author":"Kaavya","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ensci.2020.100270_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-020-01274-w","article-title":"Does retina play a role in Parkinson\u2019s disease?","volume":"120","author":"Mohana","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.ensci.2020.100270_bb0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09723757.2016.11886293","article-title":"Screening of genetic mutations in early onset parkinsonism patients: a family based study in Tamil Nadu population","volume":"16","author":"Dhivya","year":"2016","journal-title":"Int. J. Hum. Genet."},{"key":"10.1016\/j.ensci.2020.100270_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ensci.2020.100270_bb0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ensci.2020.100270_bb0030","doi-asserted-by":"crossref","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ensci.2020.100270_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2, 3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ensci.2020.100270_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BST20150133","article-title":"Dynamics of NAD-metabolism: everything but constant","volume":"43","author":"Opitz","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ensci.2020.100270_bb0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cmet.2018.01.004","article-title":"Kynurenic acid and Gpr35 regulate adipose tissue energy homeostasis and inflammation","volume":"27","author":"Agudelo","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.ensci.2020.100270_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13073-016-0296-x","article-title":"Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions","volume":"8","author":"Zhang","year":"2016","journal-title":"Genome. Med."},{"key":"10.1016\/j.ensci.2020.100270_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","article-title":"Kynurenine pathway metabolism and the microbiota-gut-brain axis","volume":"112","author":"Kennedy","year":"2017","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0060","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.1604453113","article-title":"Tryptophan-2, 3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites","volume":"113","author":"Breda","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ensci.2020.100270_bb0065","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ensci.2020.100270_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/474135","article-title":"The genetic link between Parkinson\u2019s disease and the kynurenine pathway is still missing","author":"T\u00f6r\u00f6k","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0085","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1111\/j.1742-4658.2011.08366.x","article-title":"Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats","volume":"278","author":"Braidy","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ensci.2020.100270_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/ars.2017.7269","article-title":"Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes","volume":"30","author":"Braidy","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ensci.2020.100270_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced Parkinson's disease","volume":"109","author":"Widner","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ensci.2020.100270_bb0100","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.25555","article-title":"3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis","volume":"28","author":"LeWitt","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ensci.2020.100270_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ensci.2020.100270_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/molecules23010191","article-title":"Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection","volume":"23","author":"Sas","year":"2018","journal-title":"Mol."},{"key":"10.1016\/j.ensci.2020.100270_bb0115","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes;a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ensci.2020.100270_bb0120","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1471-4159.2001.00335.x","article-title":"Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid","volume":"77","author":"Chiarugi","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ensci.2020.100270_bb0125","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ensci.2020.100270_bb0130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.clinbiochem.2004.02.007","article-title":"Increasing production of homocysteine and neopterin and degradation of tryptophan with older age","volume":"37","author":"Frick","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ensci.2020.100270_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.mad.2006.01.020","article-title":"Indoleamine 2, 3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality","volume":"127","author":"Pertovaara","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ensci.2020.100270_bb0140","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.1203083109","article-title":"Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation","volume":"109","author":"Van Der Goot","year":"2012","journal-title":"PNAS."},{"key":"10.1016\/j.ensci.2020.100270_bb0145","doi-asserted-by":"crossref","first-page":"S8158","DOI":"10.4137\/IJTR.S8158","article-title":"Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"La Cruz","year":"2012","journal-title":"IJTR."},{"key":"10.1016\/j.ensci.2020.100270_bb0150","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1471-4159.2009.05868.x","article-title":"Age and circadian influences on picolinic acid concentrations in human cerebrospinal fluid","volume":"108","author":"Coggan","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ensci.2020.100270_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(99)00196-X","article-title":"Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites","volume":"375","author":"Moroni","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000086295","article-title":"Age-related increase of kynurenic acid in human cerebrospinal fluid\u2013IgG and \u03b22-microglobulin changes","volume":"14","author":"Kepplinger","year":"2005","journal-title":"Neurosignals."},{"key":"10.1016\/j.ensci.2020.100270_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(92)91337-E","article-title":"Age-related changes in kynurenic acid production in rat brain","volume":"588","author":"Gramsbergen","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.ensci.2020.100270_bb0170","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jnc.14843","article-title":"Age-and disease-specific changes of the kynurenine pathway in Parkinson\u2019s and Alzheimer\u2019s disease","volume":"151","author":"Sorgdrager","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ensci.2020.100270_bb0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","article-title":"NAD+ in aging: molecular mechanisms and translational implications","volume":"23","author":"Fang","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ensci.2020.100270_bb0180","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2014.03.026","article-title":"Defective mitophagy in XPA via PARP-1 hyperactivation and NAD+\/SIRT1 reduction","volume":"157","author":"Fang","year":"2014","journal-title":"Cell J."},{"key":"10.1016\/j.ensci.2020.100270_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110841","article-title":"Kynurenine pathway, NAD+ synthesis, and mitochondrial function: targeting tryptophan metabolism to promote longevity and healthspan","volume":"132","author":"Castro-Portuguez","year":"2020","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ensci.2020.100270_bb0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0304-4165(82)90379-8","article-title":"The preferred route of kynurenine metabolism in the rat","volume":"717","author":"Bender","year":"1982","journal-title":"BBA\u2013Gen Sub."},{"key":"10.1016\/j.ensci.2020.100270_bb0195","doi-asserted-by":"crossref","first-page":"S4779","DOI":"10.4137\/IJTR.S4779","article-title":"Kynurenine pathway metabolism is involved in the maintenance of the intracellular NAD+ concentration in human primary astrocytes","volume":"3","author":"Grant","year":"2010","journal-title":"IJTR"},{"key":"10.1016\/j.ensci.2020.100270_bb0200","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0006-2952(03)00464-7","article-title":"Inhibition of indoleamine 2, 3-dioxygenase activity in IFN-\u03b3 stimulated astroglioma cells decreases intracellular NAD levels","volume":"66","author":"Grant","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0205","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917751636","article-title":"Indoleamine 2, 3-Dioxygenase activity increases NAD+ production in IFN-\u03b3\u2013stimulated human primary mononuclear cells","volume":"11","author":"Grant","year":"2018","journal-title":"IJTR"},{"key":"10.1016\/j.ensci.2020.100270_bb0210","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/NEN.0b013e3181f7e7e9","article-title":"Inhibition of the kynurenine-NAD+ pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis","volume":"69","author":"Bellac","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ensci.2020.100270_bb0215","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0306-4522(96)00655-0","article-title":"Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid","volume":"78","author":"Miranda","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ensci.2020.100270_bb0220","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/716859","article-title":"The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease","author":"Zinger","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s007020200020","article-title":"Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum","volume":"109","author":"Wu","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ensci.2020.100270_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(98)00577-0","article-title":"Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain","volume":"802","author":"Rassoulpour","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ensci.2020.100270_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115439","article-title":"Biochemical, histopathological and morphological profiling of a rat model of early immune stimulation: relation to psychopathology","volume":"10","author":"Kubesova","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ensci.2020.100270_bb0240","doi-asserted-by":"crossref","first-page":"PL91","DOI":"10.1016\/0024-3205(90)90376-3","article-title":"Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism","volume":"47","author":"Graham","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.ensci.2020.100270_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870060208","article-title":"Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate","volume":"6","author":"Brotchie","year":"1991","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.ensci.2020.100270_bb0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00401-006-0086-4","article-title":"Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra","volume":"112","author":"Knyih\u00e1r-Csillik","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ensci.2020.100270_bb0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejcb.2008.03.003","article-title":"Kynurenic acid attenuates MPP+-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway","volume":"87","author":"Lee","year":"2008","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ensci.2020.100270_bb0260","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ntt.2010.10.002","article-title":"Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy","volume":"33","author":"Silva-Adaya","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ensci.2020.100270_bb0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.07.006","article-title":"Kynurenine metabolism in plasma and in red blood cells in Parkinson\u2019s disease","volume":"239","author":"Hartai","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ensci.2020.100270_bb0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00702-006-0562-y","article-title":"Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?","volume":"114","author":"Wu","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ensci.2020.100270_bb0275","article-title":"Peripheral tryptophan-kynurenine metabolism associated with metabolic syndrome is different in Parkinson\u2019s and Alzheimer\u2019s diseases, Endocrinol","volume":"1","author":"Oxenkrug","year":"2017","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.ensci.2020.100270_bb0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington\u2019s disease cerebral cortex","volume":"108","author":"Beal","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ensci.2020.100270_bb0285","first-page":"1702","article-title":"Kynurenine pathway abnormalities in Parkinson's disease","volume":"42","author":"Ogawa","year":"1992","journal-title":"J. Neurol."},{"key":"10.1016\/j.ensci.2020.100270_bb0290","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.14104","article-title":"Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia","volume":"142","author":"Havelund","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ensci.2020.100270_bb0295","series-title":"Developments in Tryptophan and Serotonin Metabolism","first-page":"167","article-title":"Quinolinic acid in the pathogenesis of Alzheimer\u2019s disease","author":"Guillemin","year":"2003"},{"key":"10.1016\/j.ensci.2020.100270_bb0300","doi-asserted-by":"crossref","first-page":"IJTR","DOI":"10.4137\/IJTR.S7986","article-title":"Stochastic resonance activity influences serum tryptophan metabolism in healthy human subjects","volume":"4","author":"Kepplinger","year":"2011","journal-title":"IJTR"},{"key":"10.1016\/j.ensci.2020.100270_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2019.109606","article-title":"Study of metabolic disorders associated with BDE-47 exposure in Drosophila model by MS-based metabolomics","volume":"184","author":"Ji","year":"2019","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ensci.2020.100270_bb0310","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/antiox8100476","article-title":"Coordination complex formation and redox properties of kynurenic and xanthurenic acid can affect brain tissue homeodynamics","volume":"8","author":"Kubicova","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ensci.2020.100270_bb0315","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00401-008-0355-5","article-title":"A not entirely benign procedure: progression of Parkinson\u2019s disease","volume":"115","author":"Del Tredici","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ensci.2020.100270_bb0320","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson's disease","volume":"21","author":"Mulak","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ensci.2020.100270_bb0325","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2012.07.018","article-title":"Expression pattern and localization of alpha-synuclein in the human enteric nervous system","volume":"48","author":"B\u00f6ttner","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0330","doi-asserted-by":"crossref","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ensci.2020.100270_bb0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0340","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s00018-017-2550-9","article-title":"Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis","volume":"74","author":"Westfall","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ensci.2020.100270_bb0345","doi-asserted-by":"crossref","DOI":"10.1177\/1178646919852996","article-title":"Microorganisms, tryptophan metabolism, and kynurenine pathway: a complex interconnected loop influencing human health status","volume":"12","author":"Dehhaghi","year":"2019","journal-title":"IJTR."},{"key":"10.1016\/j.ensci.2020.100270_bb0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","article-title":"Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism","volume":"8","author":"Gao","year":"2018","journal-title":"Front Cell Infect. Mi."},{"key":"10.1016\/j.ensci.2020.100270_bb0355","doi-asserted-by":"crossref","first-page":"193ra91","DOI":"10.1126\/scitranslmed.3006438","article-title":"Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism","volume":"5","author":"Vujkovic-Cvijin","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ensci.2020.100270_bb0360","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2015.12.004","article-title":"Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders","volume":"112","author":"O\u2019Farrell","year":"2017","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0365","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2015.07.001","article-title":"Quantifying diet-induced metabolic changes of the human gut microbiome","volume":"22","author":"Shoaie","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ensci.2020.100270_bb0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fmicb.2014.00146","article-title":"Immune modulation of the brain-gut-microbe axis","volume":"5","author":"El Aidy","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ensci.2020.100270_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065790","article-title":"Targeting the microbiota to address diet-induced obesity: a time dependent challenge","volume":"8","author":"Clarke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ensci.2020.100270_bb0380","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ensci.2020.100270_bb0385","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.jmb.2018.08.002","article-title":"Quinolinic acid amyloid-like fibrillar assemblies seed \u03b1-synuclein aggregation","volume":"430","author":"Tavassoly","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ensci.2020.100270_bb0390","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coph.2019.08.004","article-title":"Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis","volume":"48","author":"Gheorghe","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0395","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.2174\/1381612822666160906161513","article-title":"Gut permeability and microbiota in Parkinson\u2019s disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways","volume":"22","author":"Anderson","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ensci.2020.100270_bb0400","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mrrev.2018.03.001","article-title":"Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases","volume":"776","author":"Boros","year":"2018","journal-title":"Mutat. Res. Rev. Mutat."},{"key":"10.1016\/j.ensci.2020.100270_bb0405","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/hmg\/10.15.1611","article-title":"Chromosome 1 loci in finnish schizophrenia families","volume":"10","author":"Ekelund","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ensci.2020.100270_bb0410","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/321969","article-title":"Schizophrenia and affective disorders\u2014cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family","volume":"69","author":"Blackwood","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ensci.2020.100270_bb0415","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/318788","article-title":"Genome-wide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32. 2, 5q33. 2, and 8p21\u201322 and provides support for linkage to schizophrenia, on chromosomes 11q23. 3\u201324 and 20q12. 1\u201311.23","volume":"68","author":"Gurling","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ensci.2020.100270_bb0420","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JPD-171240","article-title":"Is the enzyme ACMSD a novel therapeutic target in Parkinson\u2019s disease?","volume":"7","author":"Thirtamara-Rajamani","year":"2017","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0425","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2019.03.019","article-title":"Association of three candidate genetic variants in ACMSD\/TMEM163, GPNMB and BCKDK\/STX1B with sporadic Parkinson\u2019s disease in Han Chinese","volume":"703","author":"Wang","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ensci.2020.100270_bb0430","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3489638","article-title":"Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B are not associated with Parkinson\u2019s disease in Taiwan","author":"Chang","year":"2019","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002548","article-title":"Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease genetics: the PDGene database","volume":"8","author":"Lill","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ensci.2020.100270_bb0440","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e318264e353","article-title":"Large-scale replication and heterogeneity in Parkinson disease genetic loci","volume":"79","author":"Sharma","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.ensci.2020.100270_bb0445","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.neurobiolaging.2012.10.019","article-title":"Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease","volume":"34","author":"Pihlstr\u00f8m","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ensci.2020.100270_bb0450","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2016.06.001","article-title":"Genome-wide assessment of Parkinson\u2019s disease in a southern Spanish population","volume":"45","author":"Bandr\u00e9s-Ciga","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ensci.2020.100270_bb0455","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ensci.2020.100270_bb0460","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ensci.2020.100270_bb0465","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00109-013-1075-4","article-title":"The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism","volume":"91","author":"Mart\u00ed-Mass\u00f3","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ensci.2020.100270_bb0470","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JPD-171146","article-title":"A novel p. Glu298Lys mutation in the ACMSD gene in sporadic Parkinson\u2019s disease","volume":"7","author":"Vilas","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ensci.2020.100270_bb0475","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","article-title":"Blood-based biomarkers for Parkinson\u2019s disease","volume":"20","author":"Chahine","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ensci.2020.100270_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094839","article-title":"Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology","volume":"9","author":"Burgos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ensci.2020.100270_bb0485","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/pr500807t","article-title":"LC\u2013MS-based urinary metabolite signatures in idiopathic Parkinson\u2019s disease","volume":"14","author":"Luan","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ensci.2020.100270_bb0490","doi-asserted-by":"crossref","first-page":"13888","DOI":"10.1038\/srep13888","article-title":"Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson\u2019s diseas","volume":"5","author":"Luan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ensci.2020.100270_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134576","article-title":"Impaired metabolism of kynurenine and its metabolites in CSF of parkinson\u2019s disease","volume":"714","author":"Iwaoka","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ensci.2020.100270_bb0500","doi-asserted-by":"crossref","unstructured":"K.H. Chang, M.L. Cheng, H.Y. Tang, C.Y. Huang, Y.R. Wu, C.M. Chen, Alternations of metabolic profile and kynurenine metabolism in the plasma of Parkinson's disease, Mol. Neurobiol. 55 (2018) 6319\u20132638. doi:https:\/\/doi.org\/10.1007\/s12035-017-0845-3.","DOI":"10.1007\/s12035-017-0845-3"},{"key":"10.1016\/j.ensci.2020.100270_bb0505","first-page":"231","article-title":"Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders","volume":"48","author":"Ravikumar","year":"2000","journal-title":"Neurol. India"},{"key":"10.1016\/j.ensci.2020.100270_bb0510","first-page":"285","article-title":"Kynurenines, Parkinson\u2019s disease and other neurodegenerative disorders: preclinical and clinical studies","author":"Nemeth","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.ensci.2020.100270_bb0515","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00702-011-0694-6","article-title":"Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro","volume":"119","author":"Stachowski","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ensci.2020.100270_bb0520","doi-asserted-by":"crossref","first-page":"13792","DOI":"10.1016\/S0021-9258(17)36717-0","article-title":"Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase","volume":"269","author":"Malherbe","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ensci.2020.100270_bb0525","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0960-894X(95)00255-R","article-title":"Synthesis and activity of enantiopure (S)(m-nitrobenzoyl) alanine, potent kynurenine-3-hydroxylase inhibitor","volume":"5","author":"Natalini","year":"1995","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ensci.2020.100270_bb0530","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2013.08.002","article-title":"Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway","volume":"76","author":"Fukuyama","year":"2014","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0535","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","article-title":"Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection","volume":"279","author":"Stone","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.ensci.2020.100270_bb0540","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/0960-894X(95)00544-0","article-title":"Synthesis and biological activity of a series of 4-aryl substituted benz [b] azepines: antagonists at the strychnine-insensitive glycine site","volume":"5","author":"Jackson","year":"1995","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ensci.2020.100270_bb0545","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(96)00829-1","article-title":"Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo","volume":"319","author":"Wu","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0550","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(00)00024-8","article-title":"Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus","volume":"390","author":"Wu","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ensci.2020.100270_bb0555","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(01)01791-8","article-title":"Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo","volume":"304","author":"Lee","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ensci.2020.100270_bb0560","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(00)01962-4","article-title":"Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents","volume":"860","author":"Battaglia","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ensci.2020.100270_bb0565","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/mds.20459","article-title":"Pathophysiology of motor fluctuations in Parkinson\u2019s disease","volume":"20","author":"Widnell","year":"2005","journal-title":"J Mov. Disord."},{"key":"10.1016\/j.ensci.2020.100270_bb0570","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00702-011-0697-3","article-title":"Kynurenines in Parkinson\u2019s disease: therapeutic perspectives","volume":"119","author":"Z\u00e1dori","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ensci.2020.100270_bb0575","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainresbull.2011.03.008","article-title":"Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in mice","volume":"85","author":"Acu\u00f1a-Castroviejo","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ensci.2020.100270_bb0580","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/exnr.1999.7284","article-title":"In situ produced 7-chlorokynurenate provides protection against quinolinate-and malonate-induced neurotoxicity in the rat striatum","volume":"163","author":"Guidetti","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ensci.2020.100270_bb0585","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ensci.2020.100270_bb0590","doi-asserted-by":"crossref","first-page":"513","DOI":"10.33549\/physiolres.931049","article-title":"Integrative hypothesis for Huntington\u2019s disease: a brief review of experimental evidence","volume":"56","author":"Perez-De La Cruz","year":"2007","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ensci.2020.100270_bb0595","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbr.2007.08.007","article-title":"Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys","volume":"186","author":"Gr\u00e9goire","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ensci.2020.100270_bb0600","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12031-008-9137-8","article-title":"Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias","volume":"38","author":"Ouattara","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ensci.2020.100270_bb0605","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/mds.20596","article-title":"Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in parkinsonian monkeys","volume":"20","author":"Samadi","year":"2005","journal-title":"J. Mov. Disord."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650220300496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650220300496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:18:26Z","timestamp":1762503506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650220300496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":121,"alternative-id":["S2405650220300496"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2020.100270","relation":{},"ISSN":["2405-6502"],"issn-type":[{"value":"2405-6502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine pathway in Parkinson's disease\u2014An update","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2020.100270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100270"}}